This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
According to recent data, nearly 79% of cannabis users prefer smoking the plant (National Academies of Sciences, Engineering, and Medicine, 2017). Why Smoking Cannabis Isn’t Suitable for Asthma Patients Cannabis smoke, like all smoke, contains irritants and toxins that can aggravate asthma symptoms. Vuolo et al.,
Ask any seasoned cannabis nurse or patient advocate, and you’ll likely hear powerful affirmations like: “Cannabis saved my life.” Let’s explore the top three symptoms and reasons why people are using medical cannabis today—supported by research, clinical evidence, and a growing body of patient-centered care practices.
CBD for Pets: A Growing Global Conversation In a recent feature for New Frontier Data, Avida Global’s Global Strategy Director, Heidi Whitman , shared insights on the growing use of CBD for pets—especially in Europe and the U.K. for years, international markets are now following suit. At CMed, we believe wellness isn’t one-size-fits-all.
Preliminary data*, released on request from the Pennsylvania State Police Uniform Crime Reporting System, reveals that overall arrests for marijuana possession showed a decline in 2019. The new data shows 19,990 adults arrested for the same offense in 2019. cannabis arrest data since 2008.
Patients purchased an estimated $112 million worth of medical cannabis-related products in 2019, according to newly released Maine tax data. million) came from sales by caregivers to patients. Only the state’s lobster industry and potato industry bring in more annual revenue.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
According to data from the Virginia Criminal Sentencing Commission, more than 15,000 people were convicted for a first or second marijuana possession offense from July 2018 to June 2019. The program is expected to be operational and dispensing cannabis products to authorized patients by mid-year.
Data published today in the weekly publication of the US Centers for Disease Control and Prevention provides further evidence that the presence of vitamin E acetate (oil) in illicit market, e-liquid vape products is likely associated with EVALI (e-cigarette or vaping product use-associated lung injury).
Introduced was The Ending Federal Marijuana Prohibition Act of 2019, to remove marijuana from the federal Controlled Substances list and allow states the freedom to regulate marijuana as they choose, without federal interference. “The Ending Federal Prohibition Act is about acknowledging political, scientific, and economic reality. .
In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.
According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. The results?
New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).
Today, I introduced the Marijuana Justice Act of 2019 and I have every intention of moving the bill forward, but I need your help. According to recently released nationwide survey data, a supermajority of Americans strongly support patients’ access to medical marijuana and oppose federal interference in these matters.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.
The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.
THE UK’s first National Health Service patients registry will start collating data from Thursday this week in a significant move for medical cannabis in the country. However, with the database not yet available to the nation’s private clinics there are concerns over the quality and volume of data it will garner.
Date discovered : December 24, 2019. Date owners contacted : December 26, 2019. Report: Cannabis Users’ Sensitive Data Exposed in Data Breach. Led by internet privacy researchers Noam Rotem and Ran Locar, vpnMentor’s research team discovered a data breach in THSuite, a point-of-sale system in the cannabis industry.
Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.
16, 2020, but a report released earlier this month revealed the extent to which licensed patients were lined up for access. The Missouri Department of Health and Senior Services (DHSS) issued 56,448 new patient licenses and 12,062 renewed patient licenses between Dec. 6, 2019, and Dec. of patients.
The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus. And its conclusion?
Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.
The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day.
2019 is shaping up to be the most significant year in the marijuana reform movement to date and it’s a testament to one thing: That people just like you are getting involved and changing laws. You can get your 2019 membership card now by making a one-time contribution of $35 or more to invest in a brighter and freer future.
WHILE Italy is both one of the earliest and largest medical cannabis markets in Europe, new data has revealed the ongoing inability of its system to ‘serve patients’ needs’. The Italian Military’s Monopoly On Medical Cannabis Production Is Strangling Market Growth New Data Suggests. Undersupply. Read full article.
Big data and technology have become critical to a wide variety of industries in recent years, and the cannabis industry is no exception. Through advanced data collection and the application of sophisticated algorithms, usable data is now available to help marijuana businesses: Predict trends. Met consumer demands. Reduce costs.
Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. In 2019, the island’s economy grew by 2.1% billion, servicing nearly 340,000 active patients. in real terms to £4.97 RYAH Group, Inc.
In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% of the patients identified as white, including 96% in Maine.
Showing more promise is medical marijuana, which has been found in studies to cut both headache severity and migraine severity nearly in half, which is excellent news for the millions of American men and women – and almost the 1 billion patients worldwide – who suffer from migraine pain. Marijuana & Migraines: New Research Study.
January 31, 2019. Portland, OR — Today the Oregon Liquor Control Commission provided the Oregon Legislative Assembly with the 2019 Recreational Marijuana Supply and Demand Legislative Report required by ORS 475B.548. 2019 Recreational Marijuana Supply and Demand Legislative Report. Here’s the statement in full.
GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an adjunctive therapy for seizures associated with Lennox Gastaut syndrome (LGS) or Dravet syndrome, in conjunction with clobazam, for patients two years of age and older.
Under Michigan law, licensed dispensaries are permitted to sell to registered patients from other states with legal medical cannabis. Historical data from the Ohio Medical Marijuana Control Program indicates that, as of the end of September, a tenth of an ounce of plant material (flower) cost $28.81 or $288.10
To some extent, cannabis has already been decriminalized for personal use in Israel since 2019, when a law went into effect that reduced the penalties for small-scale possession to a simple fine instead of criminal charges. A decision is made by the director, and the patient has the ability to appeal a rejection to the appeal committee.
In October 2018, I left my position as a Senior Data Scientist at Anne Arundel Medical Center to focus my efforts on Peninsula Alternative Health and our technology and data needs. It’s been an exciting transition ending 2018, and I’m looking forward to what 2019 has to offer. This is something we will be addressing in 2019.
Over the first year of adult-use sales , from November 2018 to November 2019, 33 Marijuana Retailers generated $393.7 million for the full calendar year of 2019. million in gross sales, before licensees ultimately tallied $444.9 This past May, the Commission launched the license application for Marijuana Delivery Operators.
Moreover over half of current cannabis users (52%) used apps on their mobile phone/tablet yesterday, with 66% reporting mobile app usage in the past week, and 74% reporting use in the past month, according to Vividata’s Spring Cannabis Consumer Study 2019. Virtual Clinical Trials transcend geographic, mobility and economic barriers.
The Illinois Department of Public Health (IDPH), after confirming votes from the Medical Cannabis Advisory Board (MCAB), officially added four new conditions to the list of qualifying debilitating condition for Illinois patients in the Compassionate Use of Medical Cannabis Program. There may be a wide variety of causes for this syndrome.
annually — is one of the most common reasons why medical marijuana is sought out by patients in the United States, Canada, and beyond. The team peered into the findings of numerous articles published between 2001 and 2019. Chronic pain —a condition that affects 50.2 million people in the U.S.
Dr. Goldstein has treated thousands of patients with medical cannabis. It’s noteworthy that much of this anecdotal data is supported by findings from preclinical research. I have used it in some of my patients with autism. There are pharmaceuticals for ADHD or behavioral issues, for example, which target this receptor.
12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. 14th at 11:00 a.m. PT (2:00 p.m.
Texas’ medical cannabis program is in the midst of a massive spike in patient registrations. According to the Texas Department of Public Safety Chief Wayne Muller, the state has averaged a 10% month-over-month increase in medical cannabis patients over the last 18 months. Texas’ Medical Cannabis Program Sees Growth Despite Limitations.
Beckley Psytech aims to track and improve patient experience through an integrated, digitally-assisted treatment model. This latest partnership further strengthens Beckley Psytech’s digital strategy to develop personalised, end-to-end treatment programmes for patients in areas of significant unmet medical need.
The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.
November 2019, during a meeting at Flesor’s Candy Kitchen (a central Illinois gem), our web designer agreed to create an Illinois News Joint website. It’s hard to believe Illinois News Joint has reached its fourth year as a publication. A month later, the premiere resource for the Illinois cannabis industry was born.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content